CBLL vs MS · rev $65.4M vs P/E 20, $344.27B cap
CeriBell, Inc (CBLL) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
CeriBell, Inc (CBLL) is a medical devices company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported CBLL revenue for 2024-12-31 was $65.4M. Net income was -$40.5M. Revenue was up 44.7% from 2023-12-31 to 2024-12-31. CBLL currently screens at market cap $768.1M.
MS does not have a complete income-statement cache yet.
CBLL currently screens at market cap $768.1M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CBLL and MS stock pages for the full models.
Not investment advice.